Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Biolabs LA at The Lundquist Institute reaches highly significant capacity milestone

BioLabs LA at The Lundquist Institute, a co-working and incubator facility for high-potential bioscience start-ups, has reached 100% capacity ahead of schedule.

3 Aug 2021

LondonOC develops new, non-invasive technique to apply Xen stent into the eye

The London Ophthalmology Centre (LondonOC) has developed a new, non-invasive technique for the application of Xen stent into the eye to treat acute glaucoma. The micro device and new technique was successfully used to save the sight of former Children’s Laureate, Michael Rosen.

31 Jul 2021

Researchers develop new exosome formulation to deliver VEGF antibodies for synergistic therapy

Researchers from the Institute of Process Engineering of the Chinese Academy of Sciences, Beijing Chaoyang Hospital and the University of Queensland have developed a new formulation based on regulatory T-cell exosomes (rEXS) to deliver vascular endothelial growth factor (VEGF) antibodies for choroidal neovascularization therapy.

26 Jul 2021

More progress with promising new genetic test for glaucoma

The latest investigation into a promising new genetic test for glaucoma - the leading cause of blindness worldwide - has found it has the ability to identify 15 times more people at high risk of glaucoma than an existing genetic test.

15 Jul 2021

Discovery of blood biomarker opens new perspectives for dietary prevention of AMD-related risks

Age-related macular degeneration (AMD) is the principal cause of vision loss in industrialised countries, with nearly 20 million people affected in Europe in 2020. Although identified as a risk factor, until now it was impossible to evaluate retinal omega-3 fatty acid deficits.

30 Jun 2021

Study sheds new light on the function of a sight-saving growth factor

Researchers at the National Eye Institute (NEI) have determined how certain short protein fragments, called peptides, can protect neuronal cells found in the light-sensing retina layer at the back of the eye.

17 Jun 2021

New mathematical model helps simulate progression of age-related macular degeneration

Researchers from the Universidad Carlos III de Madrid (UC3M) have created a mathematical model and simulated numerically the progression of age-related macular degeneration, one of the main causes of blindness.

14 Jun 2021

AI could predict treatment demand for chronic eye diseases

Age-related macular degeneration (AMD) is the most common cause of vision loss in people over 50. Up to 12 percent of those over 80 have the chronic disease.

8 Jun 2021

Researchers identify new approach to clear toxic Huntingtin protein

Researchers world-wide are focused on clearing the toxic mutant Huntingtin protein that leads to neuronal cell death and systemic dysfunction in Huntington's disease (HD), a devastating, incurable, progressive neurodegenerative genetic disorder.

2 Jun 2021

New printable device could restore sight to blind people

A researcher at the University of Sydney is developing a printable device that acts like a retina and could one day restore sight to blind people.

17 May 2021

Research into octopus vision leads to a quick and easy test for incurable sight loss

University of Bristol research into octopus vision has led to a quick and easy test that helps optometrists identify people who are at greater risk of macular degeneration, the leading cause of incurable sight loss.

4 May 2021

New photoreceptors from human pluripotent stem cells restores sight to injured retinas

Tens of millions of people worldwide are affected by diseases like macular degeneration or have had accidents that permanently damage the light-sensitive photoreceptors within their retinas that enable vision.

22 Apr 2021

Gene therapy may offer a new approach to preserving vision in people with retinitis pigmentosa

A gene therapy protects eye cells in mice with a rare disorder that causes vision loss, especially when used in combination with other gene therapies, shows a study published today in eLife.

13 Apr 2021

Researchers identify new potential mechanism for age-related macular degeneration

Using laboratory-grown roundworms as well as human and mouse eye tissue, University of Maryland School of Medicine (UMSOM) researchers have identified a new potential mechanism for age-related macular degeneration-;the leading cause of blindness among older adults.

13 Apr 2021

Researchers make a breakthrough in the quest for an AMD cure

Age-related macular degeneration (AMD), which leads to a loss of central vision, is the most frequent cause of blindness in adults 50 years of age or older, affecting an estimated 196 million people worldwide. There is no cure, though treatment can slow the onset and preserve some vision.

29 Mar 2021

NYSCF is developing new stem cell therapy to treat age-related macular degeneration

The New York Stem Cell Foundation (NYSCF) today announced that they are developing a stem cell therapy to treat patients suffering from age-related macular degeneration (AMD).

22 Mar 2021

A better qPCR pipetting experience with VIAFLO electronic pipettes

INTEGRA Biosciences’ VIAFLO electronic pipettes are making qPCR plate preparation the straightforward process it should be for researchers in the Saint-Geniez lab at Harvard Medical School.

From INTEGRA Biosciences 17 Mar 2021

New study aims to develop alternative treatment for posterior eye diseases

Getting poked in the eye with a sharp object is a cringeworthy thought. However, many patients with posterior eye diseases -- back of the eye diseases such as macular degeneration or diabetic retinopathy -- undergo eye injections through the wall of the eye as a medical treatment on a regular basis.

16 Mar 2021

Research reveals link between proteins causing Alzheimer's disease and age-related sight loss

Newly published research has revealed a close link between proteins associated with Alzheimer's disease and age-related sight loss.

10 Mar 2021

Phase 2 clinical trial is now open at Columbia to test gene therapy for dry macular degeneration

A phase 2 clinical trial is underway at Columbia University and NewYork-Presbyterian to test an investigational gene therapy for dry age-related macular degeneration, a progressive, chronic eye disease with no cure and a leading cause of blindness in the United States.

9 Mar 2021

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Biolabs LA at The Lundquist Institute reaches highly significant capacity milestone

LondonOC develops new, non-invasive technique to apply Xen stent into the eye

Researchers develop new exosome formulation to deliver VEGF antibodies for synergistic therapy

More progress with promising new genetic test for glaucoma

Discovery of blood biomarker opens new perspectives for dietary prevention of AMD-related risks

Study sheds new light on the function of a sight-saving growth factor

New mathematical model helps simulate progression of age-related macular degeneration

AI could predict treatment demand for chronic eye diseases

Researchers identify new approach to clear toxic Huntingtin protein

New printable device could restore sight to blind people

Research into octopus vision leads to a quick and easy test for incurable sight loss

New photoreceptors from human pluripotent stem cells restores sight to injured retinas

Gene therapy may offer a new approach to preserving vision in people with retinitis pigmentosa

Researchers identify new potential mechanism for age-related macular degeneration

Researchers make a breakthrough in the quest for an AMD cure

NYSCF is developing new stem cell therapy to treat age-related macular degeneration

A better qPCR pipetting experience with VIAFLO electronic pipettes

New study aims to develop alternative treatment for posterior eye diseases

Research reveals link between proteins causing Alzheimer's disease and age-related sight loss

Phase 2 clinical trial is now open at Columbia to test gene therapy for dry macular degeneration

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in